Subtopic Deep Dive
NF-κB Signaling in IBD
Research Guide
What is NF-κB Signaling in IBD?
NF-κB signaling in IBD is the Nuclear Factor-κB pathway activation driving chronic mucosal inflammation via cytokine production and epithelial barrier dysfunction in Crohn's disease and ulcerative colitis.
NF-κB regulates pro-inflammatory genes in intestinal macrophages and epithelial cells during IBD flares (Atreya et al., 2008, 791 citations). Lamina propria macrophages show elevated NF-κB in Crohn's disease patients (Neurath et al., 1998, 220 citations). Over 10 papers from 1998-2019 detail its role, with NOD2 interactions activating NF-κB (Thiébaut et al., 2016, 207 citations).
Why It Matters
NF-κB drives cytokine transcription like IL-6 in IBD lamina propria cells, making it a target for therapies (Neurath et al., 1998). Probiotics downregulate NF-κB-related cytokines in chronic IBD models (Matsumoto et al., 2005, 221 citations). Sodium butyrate inhibits NF-κB-mediated inflammation and preserves epithelial integrity in TNBS-induced colitis (Chen et al., 2018, 536 citations). Pathway modulators show preclinical efficacy against barrier dysfunction (Heller et al., 2005, 1072 citations).
Key Research Challenges
Specificity of NF-κB Inhibition
Global NF-κB blockade risks immunosuppression while incomplete targeting fails to control IBD inflammation (Atreya et al., 2008). Tissue-specific roles in epithelium versus immune cells complicate selective inhibition (Neurath et al., 1998). Clinical translation lags due to off-target effects in trials.
Epithelial NF-κB Dysregulation
NF-κB in intestinal epithelium promotes barrier breakdown and apoptosis in ulcerative colitis (Heller et al., 2005). LPS modulates epithelial NF-κB permeability differently across species, hindering models (Stephens et al., 2019, 266 citations). Intrinsic epithelial regulators remain underexplored.
NOD2-NF-κB Crosstalk Genetics
NOD2 variants impair NF-κB activation against bacterial ligands in Crohn's disease (Thiébaut et al., 2016). Genetic analyses reveal new interactors but lack functional IBD validation (Cho et al., 2007, 555 citations). Translating genetics to pathway therapeutics faces variability.
Essential Papers
Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution
Frank Heller, Peter Florian, Christian Bojarski et al. · 2005 · Gastroenterology · 1.1K citations
NF‐κB in inflammatory bowel disease
Imke Atreya, Raja Atreya, Markus F. Neurath · 2008 · Journal of Internal Medicine · 791 citations
Abstract. Apart from genetic and environmental factors, the mucosal immune system of the gut plays a central role in the pathogenesis of inflammatory bowel disease (IBD). In the healthy gut, the mu...
The Genetics of Inflammatory Bowel Disease
Judy H. Cho, Casey T. Weaver · 2007 · Gastroenterology · 555 citations
Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model
Guangxin Chen, Xin Ran, Bai Li et al. · 2018 · EBioMedicine · 536 citations
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
Gary R. Lichtenstein, María T. Abreu, Russell D. Cohen et al. · 2007 · PubMed · 372 citations
See CME Quiz on page 932. See CME Quiz on page 932. The disorders collectively known as inflammatory bowel disease (IBD) include Crohn's disease (CD) and ulcerative colitis (UC). CD, initially cred...
Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner
Matthew Stephens, Pierre‐Yves von der Weid · 2019 · Gut Microbes · 266 citations
Patients presenting with Inflammatory bowel disease have been shown to exhibit an altered microbiome in both Crohn's disease and Ulcerative colitis. This shift in the microbial content led us to qu...
Probiotic<i>Lactobacillus</i>-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells
Satoshi Matsumoto, T. Hara, T Hori et al. · 2005 · Clinical & Experimental Immunology · 221 citations
Summary IL-6/STAT-3 signals play key roles in inflammatory bowel disease (IBD). It is known that Lactobacillus casei strain Shirota (LcS) improves inflammatory disorders. This study aimed to elucid...
Reading Guide
Foundational Papers
Read Atreya et al. (2008, 791 citations) first for NF-κB overview in IBD pathogenesis, then Neurath et al. (1998, 220 citations) for primary patient macrophage data, and Heller et al. (2005, 1072 citations) for epithelial barrier roles.
Recent Advances
Study Chen et al. (2018, 536 citations) for butyrate inhibition mechanisms and Thiébaut et al. (2016, 207 citations) for NOD2 interactors; Stephens et al. (2019, 266 citations) addresses microbial modulation.
Core Methods
Electrophoretic mobility shift assays quantify NF-κB DNA binding (Neurath et al., 1998); TNBS colitis models assess barrier integrity (Chen et al., 2018); co-immunoprecipitation maps NOD2-NF-κB complexes (Thiébaut et al., 2016).
How PapersFlow Helps You Research NF-κB Signaling in IBD
Discover & Search
Research Agent uses citationGraph on Atreya et al. (2008) to map 791-cited NF-κB IBD reviews, then findSimilarPapers for epithelial-specific works like Heller et al. (2005). exaSearch queries 'NF-κB epithelial intrinsic IBD' to uncover NOD2 interactions from Thiébaut et al. (2016). searchPapers filters post-2015 modulator trials.
Analyze & Verify
Analysis Agent runs readPaperContent on Neurath et al. (1998) to extract NF-κB cytokine data, then verifyResponse with CoVe against Matsumoto et al. (2005) for probiotic downregulation claims. runPythonAnalysis processes citation networks with pandas for NF-κB hub genes; GRADE grades evidence as high for Atreya et al. (2008) pathway centrality.
Synthesize & Write
Synthesis Agent detects gaps in epithelial NF-κB inhibitors via contradiction flagging across Chen et al. (2018) and Heller et al. (2005). Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations for 10-paper bibliographies, and latexCompile for IBD review manuscripts. exportMermaid generates NF-κB signaling flowcharts.
Use Cases
"Extract NF-κB activation stats from IBD patient lamina propria papers"
Research Agent → searchPapers 'NF-κB lamina propria IBD' → Analysis Agent → runPythonAnalysis (pandas aggregation of cytokine levels from Neurath 1998, Matsumoto 2005) → CSV table of p-values and fold-changes.
"Draft LaTeX figure of NOD2-NF-κB pathway in Crohn's"
Synthesis Agent → gap detection on Thiébaut 2016 + Cho 2007 → Writing Agent → latexGenerateFigure (NF-κB cascade) → latexSyncCitations → latexCompile → PDF with editable TikZ diagram.
"Find code for NF-κB simulation models from IBD papers"
Research Agent → paperExtractUrls (Chen 2018 butyrate model) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for TNBS inflammation dynamics.
Automated Workflows
Deep Research workflow scans 50+ NF-κB IBD papers via citationGraph from Atreya 2008, producing structured reports with GRADE-scored evidence tables. DeepScan applies 7-step CoVe to verify probiotic NF-κB claims (Matsumoto 2005 → Neurath 1998). Theorizer generates hypotheses on epithelial NF-κB targets from Heller 2005 and Stephens 2019 data.
Frequently Asked Questions
What defines NF-κB signaling in IBD?
NF-κB activation in macrophages and epithelium drives cytokine genes like IL-6, causing mucosal inflammation (Atreya et al., 2008; Neurath et al., 1998).
What methods study NF-κB in IBD?
Immunohistochemistry detects NF-κB in lamina propria (Neurath et al., 1998); TNBS mouse models test inhibitors like butyrate (Chen et al., 2018); NOD2 co-IP identifies interactors (Thiébaut et al., 2016).
What are key papers on NF-κB in IBD?
Atreya et al. (2008, 791 citations) reviews pathway centrality; Neurath et al. (1998, 220 citations) shows macrophage activation; Heller et al. (2005, 1072 citations) links to epithelial dysfunction.
What open problems exist in NF-κB IBD research?
Tissue-specific inhibitors lack clinical data; species-variable LPS-NF-κB effects challenge models (Stephens et al., 2019); genetic NOD2-NF-κB links need functional therapies (Cho et al., 2007).
Research Inflammatory Bowel Disease with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching NF-κB Signaling in IBD with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Inflammatory Bowel Disease Research Guide